跳至主要内容
临床试验/ACTRN12606000504516
ACTRN12606000504516招募中2 期

A randomised placebo controlled trial to evaluate the effects of a benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) combination party pill with and without alcohol on driving performance in subjects who have used BZP or BZP+TFMPP on at least 3 previous occasions.

Ministry of Health New Zealand0 个研究点目标入组 24 人开始时间: 2006年12月6日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 ot stated(—)
性别
All

入选标准

  • Used BZP or BZP+TFMPP on at least 3 previous occasions with no major adverse effects, consumes alcohol, friend of family member able to accompany on day of testing.

排除标准

  • Had a negative experience with BZP/TFMPP, psychiatric problems, taking medication that affects serotonin/dopamine, taking MAOIs [such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate)] in the last 14 days, epilepsy, asthma, high blood pressure, glaucoma, hyperthyroidism or other thyroid disorders, diabetes, difficulty micturating due to prostatic enlargement, pregnant, breastfeeding, cardiovascular disease, no valid drivers licence, lactose intolerant, cannot guarantee to avoid tomacco smoking on day of testing, cannot guarantee to avoid use of any recreational drugs from 48 hours before testing day until one week later.

研究者

发起方
Ministry of Health New Zealand

相似试验